UNICREDIT BANK/CALL/DIASORIN/90/0.1/18.09.24

UNICREDIT BANK/CALL/DIASORIN/90/0.1/18.09.24 Share Price

UC9E89

DE000HC9E896

Market Closed - Borsa Italiana 21:04:59 17/05/2024 BST
1.48 ^EUR	+1.86%

Current month	+47.31%
1 month	+83.73%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Chart UNICREDIT BANK/CALL/DIASORIN/90/0.1/18.09.24

Latest news about DIASORIN S.P.A.

DiaSorin receives clearance from US FDA for NxTAG panel	05-17	AN
DiaSorin S p A : receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2	05-16	PU
Funds move on DiaSorin and Leonardo on the Mib.	05-16	AN
Futures bullish; traders believe in Fed cut	05-16	AN

More news

Quotes 5-day view

Date	Price	Change
17/05/24	1.479	+1.79%
16/05/24	1.453	+4.83%
15/05/24	1.386	-17.99%
14/05/24	1.69	+18.60%
13/05/24	1.425	+7.06%

Real-time Borsa Italiana

Last update May 17, 2024 at 09:04 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	DIASORIN S.P.A.
Issuer	UniCredit
	UC9E89
ISIN	DE000HC9E896
Date issued	21/09/2023
Strike	90 €
Maturity	18/09/2024 (124 Days)
Parity	10 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.69 €
Lowest since issue	0.479 €
Spread	0.05 €
Spread %	3.34%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

102 EUR

Average target price

99.87 EUR

Spread / Average Target

-2.14%

Consensus